Literature DB >> 10972449

Crack-cocaine use and health status as defined by the SF-36.

R S Falck1, J Wang, R G Carlson, H A Siegal.   

Abstract

The Medical Outcomes Study Short Form 36 (SF-36) was administered to 443 not-in-treatment, crack-cocaine smokers to explore the relationship between frequency of crack, alcohol, and tobacco use, addiction to these drugs, and health status. The reliability of the SF-36 with crack smokers was also assessed. Statistically significant, negative associations emerged between frequency of crack use and all SF-36 subscales except physical functioning. There were not significant associations between frequency of alcohol or tobacco use and any SF-36 subscale. Self-assessed addiction to crack was strongly and negatively associated with all SF-36 subscales: alcohol and tobacco addiction were also negatively associated with health status, but not to the degree of crack. The SF-36 produces reliable data on the health status of crack users and, as such, may have a useful role in assessments involving crack-using populations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10972449     DOI: 10.1016/s0306-4603(99)00040-4

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  20 in total

1.  Long-term morbidity and mortality among a sample of cocaine-dependent black and white veterans.

Authors:  Joy C Yang; David Huang; Yih-Ing Hser
Journal:  J Urban Health       Date:  2006-09       Impact factor: 3.671

2.  The Role of Social Supports, Spirituality, Religiousness, Life Meaning and Affiliation with 12-Step Fellowships in Quality of Life Satisfaction Among Individuals in Recovery from Alcohol and Drug Problems.

Authors:  Alexandre B Laudet; Keith Morgen; William L White
Journal:  Alcohol Treat Q       Date:  2006

3.  The impact of illicit drug use and harmful drinking on quality of life among injection drug users at high risk for hepatitis C infection.

Authors:  Elizabeth C Costenbader; William A Zule; Curtis M Coomes
Journal:  Drug Alcohol Depend       Date:  2007-02-22       Impact factor: 4.492

4.  Continuous exposure to the competitive N-methyl-D: -aspartate receptor antagonist, LY235959, facilitates escalation of cocaine consumption in Sprague-Dawley rats.

Authors:  Richard M Allen; Linda A Dykstra; Regina M Carelli
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

5.  Self-rated health and substance use among individuals in HIV care in Rio de Janeiro, Brazil: a cross-sectional study.

Authors:  Iona K Machado; Paula M Luz; Jordan E Lake; Rodolfo Castro; Luciane Velasque; Jesse L Clark; Valdilea G Veloso; Beatriz Grinsztejn; Raquel B De Boni
Journal:  Int J STD AIDS       Date:  2017-02-02       Impact factor: 1.359

6.  Longitudinal changes in drug use severity and physical health-related quality of life among untreated stimulant users.

Authors:  Tyrone F Borders; Brenda M Booth; Russel S Falck; Carl Leukefeld; Jichuan Wang; Robert G Carlson
Journal:  Addict Behav       Date:  2009-06-06       Impact factor: 3.913

7.  Integrated Service Delivery and Health-Related Quality of Life of Individuals in Permanent Supportive Housing Who Were Formerly Chronically Homeless.

Authors:  Vanessa Schick; Lindsey Wiginton; Cathy Crouch; Ali Haider; Frances Isbell
Journal:  Am J Public Health       Date:  2019-02       Impact factor: 9.308

8.  Alcohol use and health-related quality of life among youth in Taiwan.

Authors:  Chuan-Yu Chen; Carla L Storr
Journal:  J Adolesc Health       Date:  2006-11       Impact factor: 5.012

9.  The impact of contingency management on quality of life among cocaine abusers with and without alcohol dependence.

Authors:  Leonardo F Andrade; Sheila M Alessi; Nancy M Petry
Journal:  Am J Addict       Date:  2011-11-18

10.  Health-related quality of life in young cocaine users and associated factors.

Authors:  O M Lozano; A Domingo-Salvany; M Martinez-Alonso; M T Brugal; J Alonso; L de la Fuente
Journal:  Qual Life Res       Date:  2008-08-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.